Nasdaq Inc vs uniQure N.V. Ordinary Shares — how do they compare? Nasdaq Inc trades at $92.36 (market cap $52.25B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Nasdaq Inc is far larger — about 35.3× uniQure N.V. Ordinary Shares's market cap, and Nasdaq Inc pays a 1.24% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nasdaq Inc for 126 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| NDAQ | QURE | |
|---|---|---|
Market Cap | $52.25B | $1.48B |
Volume | 2,420,834 | 2,488,780 |
Sector | Financials | Health |
52-Week High | $100.98 | $70.59 |
52-Week Low | $76.85 | $9.03 |
Typical Hold Time | 126 Days | 0 Days |
Enterprise Value | $58.71B | $728.62M |
Dividend Yield | 1.24% | — |
Signals from Pluang's Aura AI — not financial advice
Nasdaq (NDAQ) trades at $91.96, down 2.47% on the day, with a bullish technical outlook supported by moving averages. The company shows strong fundamentals with 2025 revenue of $8.26B and net income of $1.79B, achieving a 21.64% profit margin. Recent earnings beats and analyst consensus of $110.43 price target reflect confidence in growth driven by financial technology and AI initiatives.
NDAQ presents a compelling investment case with solid profitability and strategic positioning in market infrastructure. Key risks include market volatility sensitivity and debt levels, but strong cash flow and institutional support provide stability. The stock offers upside potential aligned with analyst targets, supported by recurring revenue growth and technology adoption.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →